New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking study

被引：15

作者：

Sadat-Ebrahimi, Seyed Esmaeil ^{[1
]}

Rahmani, Abbas ^{[1
]}

Mohammadi-Khanaposhtani, Maryam ^{[2
]}

Jafari, Negar ^{[3
]}

Mojtabavi, Somayeh ^{[4
]}

Faramarzi, Mohammad Ali ^{[4
]}

Emadi, Mehdi ^{[5
]}

Yahya-Meymandi, Azadeh ^{[6
]}

Larijani, Bagher ^{[7
]}

Biglar, Mahmoud ^{[7
]}

Mahdavi, Mohammad ^{[7
]}

机构：

[1] Univ Tehran Med Sci, Dept Med Chem, Fac Pharm & Pharmaceut Sci, Res Ctr, Tehran, Iran

[2] Babol Univ Med Sci, Cellular & Mol Biol Res Ctr, Hlth Res Inst, Babol Sar, Iran

[3] Univ Kansas, Fac Pharm, Dept Pharmaceut Chem, Lawrence, KS 66045 USA

[4] Univ Tehran Med Sci, Dept Pharmaceut Biotechnol, Fac Pharm & Biotechnol, Res Ctr, Tehran, Iran

[5] Babol Noshirvani Univ Technol, Elect & Comp Engn Dept, Babol Sar, Iran

[6] Univ Birjand, Dept Chem, Fac Sci, Birjand, Iran

[7] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran

来源：

MEDICINAL CHEMISTRY RESEARCH | 2020年 / 29卷 / 05期

关键词：

Phthalimide; Benzamide; 1,2,3-Triazole; Hybrid; alpha-Glucosidase; PHTHALIMIDE DERIVATIVES; MOLECULAR DOCKING; MECHANISM;

D O I：

10.1007/s00044-020-02522-7

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A new series of phthalimide-benzamide-1,2,3-triazole hybrids 8a-k as alpha-glucosidase inhibitors was designed and synthesized. The biological evaluation of compounds 8a-k against yeast alpha-glucosidase demonstrated that all they have excellent inhibitory activity in comparison with standard inhibitor acarbose. Among them, the most potent compound was compound 8d with inhibitory activity 18.5-fold more than acarbose. Kinetic study revealed that alpha-glucosidase inhibition of compound 8d was the competitive type. Furthermore, docking study suggested that compound 8d is more stable than acarbose in the active site of alpha-glucosidase.

引用

页码：868 / 876

页数：9

共 50 条

[1] New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking study
Seyed Esmaeil Sadat-Ebrahimi
Abbas Rahmani
Maryam Mohammadi-Khanaposhtani
Negar jafari
Somayeh Mojtabavi
Mohammad Ali Faramarzi
Mehdi Emadi
Azadeh Yahya-Meymandi
Bagher Larijani
Mahmoud Biglar
Mohammad Mahdavi
Medicinal Chemistry Research, 2020, 29 : 868 - 876
[2] Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study
Saeedi, Mina
Mohammadi-Khanaposhtani, Maryam
Pourrabia, Parvaneh
Razzaghi, Nima
Ghadimi, Reza
Imanparast, Somaye
Faramarzi, Mohammad Ali
Bandarian, Fatemeh
Esfahani, Ensieh Nasli
Safavi, Maliheh
Rastegar, Hossein
Larijani, Bagher
Mandavi, Mohammad
Akbarzadeh, Tahmineh
BIOORGANIC CHEMISTRY, 2019, 83 : 161 - 169
[3] A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition
Nasli-Esfahani, Ensieh
Mohammadi-Khanaposhtani, Maryam
Rezaei, Sepideh
Sarrafi, Yaghoub
Sharafi, Zeinab
Samadi, Nasser
Faramarzi, Mohammad Ali
Bandarian, Fatemeh
Hamedifar, Haleh
Larijani, Bagher
Hajimiri, Mirhamed
Mahdavi, Mohammad
ARCHIV DER PHARMAZIE, 2019, 352 (08)
[4] Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies
Asgari, Mohammad Sadegh
Mohammadi-Khanaposhtani, Maryam
Kiani, Mitra
Ranjbar, Parviz Rashidi
Zabihi, Ebrahim
Pourbagher, Roghayeh
Rahimi, Rahmatollah
Faramarzi, Mohammad Ali
Biglar, Mahmood
Larijani, Bagher
Mahdavi, Mohammad
Hamedifar, Haleh
Hajimiri, Mir Hamed
BIOORGANIC CHEMISTRY, 2019, 92
[5] Phthalimide/Naphthalimide containing 1,2,3-triazole hybrids: Synthesis and Antimicrobial Evaluation
Yadav, Priyanka
Kaushik, C. P.
Kumar, Mukesh
Kumar, Anil
JOURNAL OF MOLECULAR STRUCTURE, 2023, 1276
[6] Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies
Asgari, Mohammad Sadegh
Mohammadi-Khanaposhtani, Maryam
Sharafi, Zeinab
Faramarzi, Mohammad Ali
Rastegar, Hossein
Esfahani, Ensieh Nasli
Bandarian, Fatemeh
Rashidi, Parviz Ranjbar
Rahimi, Rahmatollah
Biglar, Mahmood
Mandavi, Mohammad
Larijani, Bagher
MOLECULAR DIVERSITY, 2021, 25 (02) : 877 - 888
[7] New thiosemicarbazide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors: Design, synthesis, and biological evaluation
Bakherad, Zohreh
Mohammadi-Khanaposhtani, Maryam
Sadeghi-Aliabadi, Hojjat
Rezaei, Sepideh
Fassihi, Afshin
Bakherad, Mohammad
Rastegar, Hossein
Biglar, Mahmood
Saghaie, Lotfollah
Larijani, Bagher
Mahdavi, Mohammad
JOURNAL OF MOLECULAR STRUCTURE, 2019, 1192 : 192 - 200
[8] Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies
Mohammad Sadegh Asgari
Maryam Mohammadi-Khanaposhtani
Zeinab Sharafi
Mohammad Ali Faramarzi
Hossein Rastegar
Ensieh Nasli Esfahani
Fatemeh Bandarian
Parviz Ranjbar Rashidi
Rahmatollah Rahimi
Mahmood Biglar
Mohammad Mahdavi
Bagher Larijani
Molecular Diversity, 2021, 25 : 877 - 888
[9] Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors
Asemanipoor, Nafise
Mohammadi-Khanaposhtani, Maryam
Moradi, Shahram
Vahidi, Mahbobeh
Asadi, Mehdi
Faramarzi, Mohammad Ali
Mahdavi, Mohammad
Biglar, Mahmood
Larijani, Bagher
Hamedifar, Haleh
Hajimiri, Mir Hamed
BIOORGANIC CHEMISTRY, 2020, 95
[10] Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies
Avula, Satya Kumar
Khan, Ajmal
Rehman, Najeeb Ur
Anwar, Muhammad U.
Al-Abri, Zahra
Wadood, Abdul
Riaz, Muhammad
Csuk, Rene
Al-Harrasi, Ahmed
BIOORGANIC CHEMISTRY, 2018, 81 : 98 - 106

← 1 2 3 4 5 →